LS
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Lesotho
Medical Only (Private)
Reimbursed Care Access
Lesotho’s national drug control framework heavily restricts classical psychedelics (psilocybin, MDMA, DMT, mescaline and many synthetic analogues) under its Drugs of Abuse Act (2008), while conventional anesthetic agents such as ketamine are used in clinical care under Ministry of Health regulation. Novel marketed psychedelic pharmaceuticals (e.g., esketamine nasal spray/Spravato) do not appear to have an established, reimbursed national pathway in Lesotho and access is limited to routine hospital use of authorised anesthetics, tightly regulated imports, or participation in approved research if any.
No clinical trials found for this country yet.